FDA Import Refusal SCS-5743649-7/21/1 — Boehringer Ingelheim India Pvt Ltd
The FDA refused shipment SCS-5743649-7/21/1 from Boehringer Ingelheim India Pvt Ltd (India) on Jun 23, 2021. The refused product falls under Drugs and Biologics — ANTI-DIABETIC N.E.C.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jun 23, 2021
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCE99 ANTI-DIABETIC N.E.C.
- Charges
- 75